Evaluation and Management of Amenorrhea with Multiple Ovarian Follicles
A reproductive-age woman with amenorrhea and polycystic-appearing ovaries should be diagnosed with PCOS if she meets two of three Rotterdam criteria (androgen excess, ovulatory dysfunction, or polycystic ovaries), after excluding thyroid disease, hyperprolactinemia, and nonclassic congenital adrenal hyperplasia with TSH, prolactin, and 17-hydroxyprogesterone testing 1.
Diagnostic Approach
Initial Mandatory Exclusions
Before diagnosing PCOS, you must rule out mimicking disorders in all women 1:
- TSH - to exclude thyroid disease
- Prolactin - to exclude hyperprolactinemia (which can present with amenorrhea or hirsutism)
- 17-hydroxyprogesterone (17-OHP) - to exclude nonclassic congenital adrenal hyperplasia (primarily 21-hydroxylase deficiency)
Rotterdam Diagnostic Criteria
The diagnosis requires two of three features 1, 2:
Androgen excess (clinical or biochemical)
- Clinical: hirsutism, acne, male-pattern hair loss
- Biochemical: elevated testosterone or other androgens
Ovulatory dysfunction
- Amenorrhea (absence of menses >3 months with regular cycles, >6 months with irregular cycles)
- Oligomenorrhea
Polycystic ovarian morphology
Important Diagnostic Nuances
You do not need universal screening with androgen assays or ultrasound if the patient already meets two criteria clinically 1. For example, a woman with clear clinical hyperandrogenism (hirsutism) and amenorrhea already meets diagnostic criteria without requiring ultrasound confirmation.
For women with amenorrhea and more severe phenotypes, consider more extensive evaluation to exclude other causes 1. This is particularly relevant when presentation is atypical or severe.
Management Framework
Core Treatment Priorities
Lifestyle modification remains first-line across all PCOS phenotypes 2:
- Address weight management without weight stigma
- Emphasize emotional wellbeing and quality of life
- Screen for psychological features (anxiety, depression, eating disorders, body image concerns) using validated questionnaires 4
Menstrual Regulation
For amenorrhea management 4, 2:
- Combined oral contraceptives - first-line for menstrual regulation and endometrial protection
- Progestins - alternative for contraceptive users or those with contraindications to estrogen
- Referral to specialist for fertility concerns or complex cases
Metabolic Screening
Cardiometabolic risk assessment is mandatory 3, 2:
- Screen for metabolic syndrome components
- Assess cardiovascular disease risk
- Evaluate for sleep apnea
- Monitor for glucose intolerance/diabetes risk
- Refer to specialist for complex metabolic profiles
Hyperandrogenic Features
If hirsutism or acne are prominent 4:
- Topical or hormonal therapy in primary care
- Escalate to anti-androgens (spironolactone, finasteride) if needed
- Dermatology referral for refractory cases
Critical Pitfalls to Avoid
Do not diagnose PCOS without excluding thyroid disease, hyperprolactinemia, and nonclassic CAH - these are comparatively easy to exclude and must be ruled out first 1
Do not over-rely on ultrasound alone - polycystic ovarian morphology is only one of three criteria and should not be used in isolation, especially in adolescents where it has limited specificity 5
Do not miss the broader disease burden - PCOS carries high risk for adverse pregnancy outcomes, psychological disturbance, metabolic syndrome, and cardiovascular disease that require proactive screening 3, 2
Document which specific features led to diagnosis - this improves consistency of care and research 1
Consider weight stigma - address lifestyle and metabolic health without perpetuating harmful weight-based messaging 2
When to Refer
Specialist referral is warranted for 4:
- Fertility management needs
- Complex metabolic profiles requiring specialized care
- Refractory hyperandrogenic symptoms
- Diagnostic uncertainty or atypical presentations
- Adolescents requiring specialized developmental considerations